Bullish Case: HII's dense funded backlog and Virginia-class/Columbia demand remain intact; the Anduril $6.6B news actually confirms acute submarine industrial-base shortage, positioning HII's Newport News as the indispensable incumbent. Call volume runs 60% above puts, Helium's density peaks at $260–270 near spot, and the return surface concentrates likelihood at modest positive holds. Any Q3 margin or award upside nudges price toward $280–300.

Bearish Case: Anduril's production-outcome-priced contract marks a structural entry of non-traditional competitors into HII's core submarine component turf, eroding moat pricing power. HII is down 6.5% y/y, -5.4% m/m, execution risk at Newport News persists, and market-implied density carries heavy $250–290 dispersion with bearish risk 4% above bullish across tenors.

Potential Outcomes:

1. 35% Rangebound $250–280: Helium density mode $260, flat IV term structure. Falsifier: sustained ±6% 30-day move.
2. 25% Re-rate +10–20% ($290–315): Q3 earnings beat, award headlines; falsifier: guidance cut.
3. 22% Correction -10–20% ($215–240): Newport News cost/schedule setback; falsifier: backlog upgrade.
4. 13% Competitive displacement pressure: Anduril ramps component share; falsifier: HII retains Virginia-class workshare.
5. 5% Tail shock (±25%): program cancellation or major procurement surprise.

October 15, 2026